Does tirzepatide withdrawal change eating behavior enough to affect public health?

Tirzepatide withdrawal can trigger rebound eating changes like increased hunger and emotional eating, potentially impacting public health through weight regain and disordered eating patterns.

Direct answer

Yes, tirzepatide withdrawal likely changes eating behavior enough to affect public health, but the evidence is indirect. The drug suppresses appetite by targeting GLP-1 and GIP receptors, and stopping it can lead to rebound increases in hunger and disinhibition—a pattern seen in similar weight-loss interventions. Across the studies here, anxiety and stress are strongly linked to disinhibited eating [5], and weight stigma is associated with disordered eating [1], both of which could worsen after withdrawal. If large numbers of people regain weight and develop unhealthy eating patterns, this could strain healthcare systems and increase obesity-related disease rates. However, no study directly measures tirzepatide withdrawal effects on eating behavior at a population level, so this remains a plausible risk rather than a proven outcome.

5sources cited

This article was generated with WisPaper-powered search and paper analysis.

Why stopping tirzepatide could disrupt eating behavior

Tirzepatide works by mimicking hormones (GLP-1 and GIP) that signal fullness and slow digestion. When you stop the drug, those signals vanish, and the brain's homeostatic and hedonic systems—which regulate hunger and reward-driven eating—must recalibrate. Research on the neurobiology of eating shows that food choices depend on a delicate balance between homeostatic (need-based), hedonic (pleasure-based), and executive (self-control) pathways [4]. Withdrawal removes a powerful brake on appetite, potentially tipping the balance toward overeating.

A large population study of over 5,000 adults found that anxiety is strongly linked to two key eating behaviors: disinhibition (loss of control over eating) and hunger [5]. After tirzepatide withdrawal, if anxiety about weight regain or loss of the drug's effect emerges, it could amplify these behaviors. The same study showed no link between anxiety and cognitive restraint (deliberate dieting), meaning people may struggle to consciously compensate for the rebound hunger [5].

What existing research tells us about rebound eating after weight-loss drugs

No study has directly tested tirzepatide withdrawal on eating behavior, but related research points to clear risks. Weight stigma—the social discrimination people with obesity face—is associated with significantly higher rates of disordered eating (b = 0.34) and comfort eating (b = 0.32), even after controlling for BMI [1]. If patients regain weight after stopping tirzepatide, they may face increased stigma, which could drive emotional eating and create a vicious cycle.

Mental health is another critical factor. A study of 424 postpartum women found that depressive symptoms and perceived stress were linked to emotional eating and external eating (eating in response to food cues) over 18 months [3]. The same study showed that self-efficacy—confidence in one's ability to eat healthily—protected against these behaviors. After tirzepatide withdrawal, if patients lose confidence in their ability to maintain weight loss, their eating behaviors may deteriorate. Health literacy also plays a role: a study of adults in Turkey found that higher health literacy predicted better eating behaviors, though it explained only 1.3% of the variation [2]. This suggests that education alone may not be enough to counteract the biological drive to eat after drug withdrawal.

Could widespread withdrawal affect public health?

If tirzepatide becomes widely used and then discontinued by many patients—due to cost, side effects, or insurance changes—the population-level impact could be substantial. The neurobiology review emphasizes that eating rate drives calorie intake, and that even small changes in food environment or behavior can shift obesity rates [4]. If withdrawal leads to increased hunger and disinhibition in millions of people, average calorie intake could rise, potentially reversing some of the public health gains from the drug's use.

However, the evidence is indirect. The studies here do not measure tirzepatide withdrawal directly, and they come from different populations (U.S. adults, Turkish adults, postpartum women) [1][2][3][5]. The strongest link comes from the anxiety-eating behavior study, which shows that psychological factors—which often worsen after stopping a successful treatment—are robustly tied to disinhibition and hunger [5]. For public health, the key question is whether healthcare systems can provide behavioral support (e.g., counseling, diet plans) during and after withdrawal to mitigate these risks. Without such support, the answer to your question leans toward 'yes, it could matter.'

About These Sources

This answer is built on 5 peer-reviewed studies — published from 2021 to 2023, 3 in Q1 journals, collectively cited 244 times — selected as the most relevant from 5 studies that passed quality screening, drawn from 34 papers retrieved from a database of over 500 million.

Sources used in this answer

1

Weight stigma and health behaviors: evidence from the Eating in America Study

In a U.S. census-matched sample of 2,022 adults, weight stigma was significantly associated with greater disordered eating (b = 0.34), comfort eating (b = 0.32), sleep disturbance, and alcohol use, independent of BMI.

2

Investigating the correlation of health literacy with eating behavior and health perception in adult individuals

In a Turkish adult sample, health literacy had a statistically significant but small positive effect on eating behavior (explaining 1.3% of variance), suggesting education alone may not overcome biological drives.

3

Mental Health, Behavior Change Skills, and Eating Behaviors in Postpartum Women

In a randomized controlled trial of 424 postpartum women over 18 months, depressive symptoms and perceived stress were linked to emotional and external eating, while self-efficacy protected against unhealthy eating behaviors.

4

Neurobiology of eating behavior, nutrition, and health

A review of neurobiology research highlights that eating behavior is controlled by homeostatic, hedonic, and executive systems, and that eating rate drives calorie intake—meaning withdrawal of appetite-suppressing drugs could increase consumption.

5

Analyzing the link between anxiety and eating behavior as a potential pathway to eating-related health outcomes

In a population-based study of 5,019 adults, anxiety was significantly positively associated with disinhibition and hunger (but not cognitive restraint), indicating that anxiety after drug withdrawal could worsen loss-of-control eating.